Insider Transactions in Q1 2021 at Exact Sciences Corp (EXAS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2021
|
Paul J Clancy |
BUY
Grant, award, or other acquisition
|
Direct |
2,929
+50.0%
|
-
|
|
Mar 11
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
43,241
-52.99%
|
$5,621,330
$130.0 P/Share
|
|
Mar 11
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,241
+20.77%
|
$1,426,953
$33.03 P/Share
|
|
Mar 08
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,612
+10.73%
|
$96,852
$21.68 P/Share
|
|
Mar 05
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
11,735
-25.8%
|
$1,419,935
$121.33 P/Share
|
|
Mar 03
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
2,664
-67.19%
|
$359,640
$135.02 P/Share
|
|
Mar 03
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,632
-6.42%
|
$355,320
$135.02 P/Share
|
|
Mar 02
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,679
-2.22%
|
$231,702
$138.42 P/Share
|
|
Mar 02
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
9,796
-1.21%
|
$1,351,848
$138.42 P/Share
|
|
Mar 02
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
4,126
-29.99%
|
$573,514
$139.36 P/Share
|
|
Mar 02
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,230
-4.79%
|
$587,970
$139.36 P/Share
|
|
Mar 02
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
2,524
-5.26%
|
$348,312
$138.42 P/Share
|
|
Mar 01
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
3,525
+4.45%
|
-
|
|
Mar 01
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,575
+2.48%
|
-
|
|
Mar 01
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
9,200
+37.44%
|
$202,400
$22.18 P/Share
|
|
Mar 01
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+10.0%
|
-
|
|
Mar 01
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+9.47%
|
-
|
|
Mar 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
31,293
-1.92%
|
$4,287,141
$137.11 P/Share
|
|
Mar 01
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
5,673
-45.24%
|
$777,201
$137.11 P/Share
|
|
Mar 01
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,098
-1.5%
|
$150,426
$137.44 P/Share
|
|
Mar 01
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,403
-8.88%
|
$1,151,211
$137.11 P/Share
|
|
Mar 01
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
1,603
-3.59%
|
$219,611
$137.44 P/Share
|
|
Feb 26
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,312
+1.12%
|
-
|
|
Feb 26
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
3,263
+41.69%
|
-
|
|
Feb 26
2021
|
James Edward Doyle |
SELL
Open market or private sale
|
Direct |
2,000
-6.16%
|
$260,000
$130.11 P/Share
|
|
Feb 26
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,357
+3.12%
|
-
|
|
Feb 26
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,437
+6.6%
|
-
|
|
Feb 26
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,263
+6.82%
|
-
|
|
Feb 26
2021
|
Michael S Wyzga Director |
SELL
Open market or private sale
|
Direct |
19,021
-88.15%
|
$2,472,730
$130.11 P/Share
|
|
Feb 26
2021
|
Michael S Wyzga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,108
+31.9%
|
$262,808
$26.98 P/Share
|
|
Feb 25
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
6,788
-83.92%
|
$896,016
$132.96 P/Share
|
|
Feb 24
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
2,057
-2.82%
|
$279,752
$136.3 P/Share
|
|
Feb 24
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
16,420
-1.99%
|
$2,233,120
$136.3 P/Share
|
|
Feb 24
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
6,062
-42.84%
|
$824,432
$136.3 P/Share
|
|
Feb 24
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,449
-8.97%
|
$605,064
$136.3 P/Share
|
|
Feb 24
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
5,842
-12.38%
|
$794,512
$136.3 P/Share
|
|
Feb 23
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,300
+5.56%
|
-
|
|
Feb 23
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,325
+3.99%
|
-
|
|
Feb 23
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
18,750
-56.99%
|
$2,550,000
$136.51 P/Share
|
|
Feb 23
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
31,600
+41.95%
|
$316,000
$10.84 P/Share
|
|
Feb 23
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,300
+15.79%
|
-
|
|
Feb 23
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,575
+19.7%
|
-
|
|
Feb 19
2021
|
Jacob A Orville EVP, GM, Screening |
SELL
Open market or private sale
|
Direct |
1,696
-23.75%
|
$242,528
$143.38 P/Share
|
|
Feb 18
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
1,980
-60.35%
|
$277,200
$140.79 P/Share
|
|
Feb 18
2021
|
Jacob A Orville EVP, GM, Screening |
BUY
Exercise of conversion of derivative security
|
Direct |
3,649
+33.82%
|
-
|
|
Feb 17
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,033
-1.48%
|
$146,686
$142.66 P/Share
|
|
Feb 17
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
15,825
-1.96%
|
$2,247,150
$142.66 P/Share
|
|
Feb 17
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
1,992
-37.78%
|
$282,864
$142.66 P/Share
|
|
Feb 17
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,020
-4.77%
|
$286,840
$142.66 P/Share
|
|
Feb 17
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
2,131
-5.65%
|
$302,602
$142.66 P/Share
|